References
- Antibodies Monoclonal Cancer, GL Wright, Jr. Marcel Dekker Inc, New York 1984
- Shi S R, Goodmann M L, Bhan A K, Pilch B Z, Chen L B, Sun IT. Immunohistochemical study of nasopharyngeal carcinoma using monoclonal keratin antibodies. Am J Pathol 1984; 117: 53–63
- Batsakis JG. Histopathological considerations. Cancer of the Head and Neck, JY Suen, EN Myers. Churchill Livingstone, Edinburgh 1981; 25–46
- Böheim K, Speak J A, Frei E, III, Bernal SD. SQM1 antibody defines a surface membrane antigen in squamous carcinoma of the head and neck. Int J Cancer 1985; 36: 137–42
- Stein H, Mason D Y, Gerdes J, O'Connor N, Wainscoat J, Pallesen G, Gatter K, Falini B, Delsol G, Lernke H, Schwarting R, Lennert K. The expression of the Hodgkin disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985; 66: 848–58
- American Joint Committee for Staging Cancer and End-Results Reporting: Manual for Staging of Cancer 1978. AJC, Chicago 1978
- Rheinwald J G, Beckett MA. Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas. Cancer Res 1981; 41: 1657–63
- Jakobsson PA. Histologic grading of malignancy and prognosis in glottic carcinoma of the larynx. Can J Otolaryngol 1975; 4: 885–92
- Böheim K, Spoendlin H. The effect of chemotherapy in relation to pathohistological tumor grading in head and neck cancer. Arch Otorhinolaryngol 1983; 238: 197–204
- Crissman J D, Liu W Y, Gluckman J L, Cummings G. Prognostic value of histopathologic parameters in squamous cell carcinoma of the oropharynx. Cancer 1984; 54: 2995–3001
- Böheim K, Speak J A, Frei E, III, Cucchi C A, Bernal SD. Diminished reactivity of SQM1 monoclonal antibody associated with methotrexate resistance of human squamous carcinoma cell lines. Proc Am Assoc Cancer Res 1985; 7152: 292, Abst